Scheduling Work During Treatment

 

Many people, with their doctors' approval, work during part or all of their cancer treatment. Your decision to work or not to work during treatment is a highly personal one that must take many factors into consideration, including your overall health, any side effects you may be experiencing, your financial situation, the type of work you do and how demanding it is, and your personal preference. You may be reluctant to stop working because it may mean putting your career on hold or losing your position in the workplace.

Going to your job and accomplishing your usual tasks may help distract you from thinking about cancer. What's more, you may simply love your work and/or the routine of going to work and are on friendly terms with co-workers, who can be good sources of support and social interaction.

No matter why you may decide you would like to continue working during treatment, there's a lot to consider, including:

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health